临床试验/NCT00370669

NCT00370669Unknown3 期

Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema

Shahid Beheshti University of Medical Sciences2 个研究点分布在 2 个国家目标入组 150 人开始时间: 2005年11月1日最近更新: 2007年2月22日

适应症

试验速览

阶段: 3 期
发起方: Shahid Beheshti University of Medical Sciences
入组人数: 150
试验地点: 2
主要终点: visual acuity

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone acetonide with laser photocoagulation on clinically significant macular edema (CSME)

详细描述

we entered 150 eyes into the study that recruitment of cases finished recently.Eligible eyes randomly assign to one of the study arms including intravitreal bevacizumzb, intravitreal bevacizumzb/triamcinolone and macular photocoagulation groups. Every patient needs at least 1 year followup. During this time BCVA, OCT, FA will be done for each patient and inaccording to interpretation of datas and fundus exam repeatation of injection will be done.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Single

入排标准

性别: All
接受健康志愿者: 否

入选标准

•case with clear media IOP below 23 mm/Hg female after menopause at least for 12 months or had 2 contraceptive roots visual acuity between 20/50 to 20/320

排除标准

•no PRP or N.d YAG laser in past 6 months no intraocular surgery in past 12 months
•CVA in past 12 months blood sugar above 250
•active infection in extraocular adnexa

结局指标

主要结局

visual acuity

central macular thickness

次要结局

Leakage in fluorescein angiography
intraocular pressure
cataract progression
anterior chamber reaction

研究者

发起方

Shahid Beheshti University of Medical Sciences

申办方类型

Other

研究点 (2)

Loading locations...

相似试验

已完成

不适用

Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCentral Retinal Vein Occlusion With Macular Edema

NCT04812977Hayatabad Medical Complex30

Unknown

3 期

Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDNeovascular Age-Related Macular Degeneration

NCT00370370Shahid Beheshti University of Medical Sciences

Unknown

3 期

Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialDiabetic Macular Edema

NCT00370422Shahid Beheshti University of Medical Sciences

已完成

不适用

Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor VisionCentral Retinal Vein Occlusion With 20/200 or Worse Visual Acuity

NCT01053858Hallym University Medical Center38

已完成

不适用

Intra ocular injection of Bevacizumab and Triamcinolone for diabetic visual loss.

CTRI/2014/09/005070ethradhama Superspeciality Eye Hospita15